Metabolic and body composition factors in subgroups of obesity: What do we know?

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 6, 2004, Pages 2569-2575

  Karelis, Antony D ^a,b   St Pierre, David H ^a   Conus, Florence ^a   Rabasa Lhoret, Remi ^a   Poehlman, Eric T ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Unite Metabolique   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GASTROINTESTINAL HORMONE;

ADIPOSE TISSUE; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; CALORIMETRY; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; DECISION MAKING; DISEASE PREDISPOSITION; ENERGY EXPENDITURE; GLUCOSE TOLERANCE; HORMONAL REGULATION; HUMAN; INSULIN SENSITIVITY; MEDICAL LITERATURE; MEDICAL RESEARCH; METABOLIC ACTIVATION; METABOLIC DISORDER; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE;

BODY COMPOSITION; ENERGY METABOLISM; HUMANS; OBESITY;

EID: 2942657651     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0165     Document Type: Conference Paper

References (40)

1. WHO 1998 Obesity. Preventing and managing the global epidemic. Geneva: WHO
2. Andres R 1980 Effect of obesity on total mortality. Int J Obes 4:381-386
3. Ruderman NB, Schneider SH, Berchtold P 1981 The "metabolically- obese," normal-weight individual. Am J Clin Nutr 34:1617-1621
4. Ruderman NB, Berchtold P, Schneider S1982 Obesity-associated disorders in normal-weight individuals: some speculations. Int J Obes 6:151-157
5. Sims EA 1982 Characterization of the syndromes of obesity, diabetes mellitus and obesity. Baltimore, London: Williams & Wilkins
6. Ferrannini E, Haffner SM, Mitchell BD, Stern MP 1991 Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34:416-422
7. Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U 1996 Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes 45:947-953
8. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalk N, Mingrone G 1997 Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest 100:1166-1173
9. Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EA, Poehlman ET 2001 What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 86:1020-1025
10. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna RC, Muggeo M 1998 Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 47:1643-1649
11. Marin P, Andersson B, Ottosson M, Olbe L, Chowdhury B, Kvist H, Holm G, Sjostrom L, Bjorntorp P 1992 The morphology and metabolism of intra-abdominal adipose tissue in men. Metabolism 41:1242-1248
12. Albu JB, Curi M, Shur M, Murphy L, Matthews DE, Pi-Sunyer FX 1999 Systemic resistance to the antilipolytic effect of insulin in black and white women with visceral obesity. Am J Physiol 277:E551-E560
13. Muscelli E, Camastra S, Gastaldelli A, Natali A, Masoni A, Pecori N, Ferrannini E 1998 Influence of duration of obesity on the insulin resistance of obese non-diabetic patients. Int J Obes Relat Metab Disord 22:262-267
14. Examination Committee of Criteria for "Obesity Disease" in Japan 2002 New criteria for 'obesity disease' in Japan. Circ J 66:987-992
15. Matsuzawa Y 1997 Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience. Diabetes Metab Rev 13:3-13
16. Oflaz H, Ozbey N, Mantar F, Genchellac H, Mercanoglu F, Sencer E, Molvalilar S, Orhan Y 2003 Determination of endothelial function and early atherosclerotic changes in healthy obese women. Diabetes Nutr Metab 16:176-181
17. Despres JP, Lamarche B 1994 Low-intensity endurance exercise training, plasma lipoproteins and the risk of coronary heart disease. J Intern Med 236:7-22
18. Brochu M, Poehlman ET, Ades PA 2000 Obesity, body fat distribution, and coronary artery disease. J Cardiopulm Rehabil 20:96-108
19. Salans LB, Cushman SW, Weismann RE 1973 Studies of human adipose tissue. Adipose cell size and number in nonobese and obese patients. J Clin Invest 52:929-941
20. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S 1998 The metabolically obese, normal-weight individual revisited. Diabetes 47:699-713
21. Dvorak RV, DeNino WF, Ades PA, Poehlman ET 1999 Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes 48:2210-2214
22. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M, et al 1989 Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320:702-706
23. Katsuki A, Sumida Y, Urakawa H, Gabazza EC, Murashima S, Maruyama N, Morioka K, Nakatani K, Yano Y, Adachi Y 2003 Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care 26:2341-2344
24. Nyholm B, Mengel A, Nielsen S, Skjaerbaek C, Moller N, Alberti KG, Schmitz O 1996 Insulin resistance in relatives of NIDDM patients: the role of physical fitness and muscle metabolism. Diabetologia 39:813-822
25. Katzel LI, Bleecker ER, Colman EG, Rogus EM, Sorkin JD, Goldberg AP 1995 Effects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men. A randomized controlled trial. JAMA 274:1915-1921
26. Sharma AM 2002 Adipose tissue: a mediator of cardiovascular risk. Int J Obes Relat Metab Disord 26:S5-S7
27. Park KS, Rhee BD, Lee KU, Kim SY, Lee HK, Koh CS, Min HK 1991 Infra-abdominal fat is associated with decreased insulin sensitivity in healthy young men. Metabolism 40:600-603
28. von Eyben FE, Mouritsen E, Holm J, Montvilas P, Dimcevski G, Suciu G, Helleberg I, Kristensen L, von Eyben R 2003 Intra-abdominal obesity and metabolic risk factors: a study of young adults. Int J Obes Relat Metab Disord 27:941-949
29. Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, Goto T, Westerbacka J, Sovijarvi A, Halavaara J, Yki-Jarvinen H 2002 Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87:3023-3028
30. Havel PJ 2002 Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol 13:51-59
31. Ikezaki A, Hosoda H, Ito K, Iwama S, Miura N, Matsuoka H, Kondo C, Kojima M, Kangawa K, Sugihara S 2002 Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents. Diabetes 51:3408-3411
32. Korbonits M, Gueorguiev M, O'Grady E, Lecoeur C, Swan DC, Mein CA, Weill J, Grossman AB, Froguel P 2002 A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children. J Clin Endocrinol Metab 87:4005-4008
33. Addy CL, Gavrila A, Tsiodras S, Brodovicz K, Karchmer AW, Mantzoros CS 2003 Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy. J Clin Endocrinol Metab 88:627-636
34. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML 2001 Circulating ghrelin levels are decreased in human obesity. Diabetes 50: 707-709
35. Milan G, Granzotto M, Scarda A, Calcagno A, Pagano C, Federspil G, Vettor R 2002 Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes Res 10:1095-1103
36. Koistinen HA, Vidal H, Karonen SL, Dusserre E, Vallier P, Koivisto VA, Ebeling P 2001 Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. Arterioscler Thromb Vasc Biol 21:1034-1039
37. Dusserre E, Moulin P, Vidal H 2000 Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta 1500:88-96
38. Katsuki A, Sumida Y, Urakawa H, Gabazza EC, Murashima S, Matsumoto K, Nakatani K, Yano Y, Adachi Y 2003 Plasma levels of adiponectin are associated with insulin resistance and serum levels of triglyceride in Japanese metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Care 26:2964-2965
39. Sims EA 2001 Are there persons who are obese, but metabolically healthy? Metabolism 50:1499-1504
40. Frayn KN 2002 Adipose tissue as a buffer for daily lipid flux. Diabetologia 45:1201-1210